Dr. Martin J. Murphy, Jr. brings four decades of healthcare and cancer research experience to his CEO Roundtable role through his extensive work as a peer-reviewed cancer scientist, professor of medicine, editor and oncology consultant. Dr. Murphy, a graduate of New York University, was awarded postdoctoral fellowships at the Institut de Pathologie Cellulaire (Paris, France), the Patterson Laboratories of the Christie Hospital and Holt Radium Institute (Manchester, UK), and the John Curtin School of Medical Research, Australian National University (Canberra, Australia). He was on the faculty of St. Jude Children's Research Hospital (Memphis, TN), Memorial Sloan-Kettering Cancer Center (New York, NY), and Wright State University School of Medicine (Dayton, OH). Dr. Murphy founded the Hipple Cancer Research Center in 1977 and led it for the next two decades as its chief executive officer. When he retired from Hipple, endeavoring to advance both new discoveries and enhance improved global healthcare delivery, Dr. Murphy founded AlphaMed Consulting that provides support for comprehensive cancer centers as well as selected research-intensive pharmaceutical and biotech companies.
Dr. Murphy is a director of Aldagen, a clinical-stage regenerative medicine company. He is a member of the Scientific Advisory Board ( Dr. Herb Boyer, chairman) of Hatteras Venture Partners, a charter member of the Scientific Advisory Board of Pappas Ventures, (2002-2008), and the primary biopharma consultant to Catellus, the developer of Mission Bay, the largest life science campus in San Francisco. He was the charter chairman of the Scientific Advisory Board of ALMAC Diagnostics (2000-2008); a founding member of Queen’s University School of Medicine International Review Board, chairman of The Conquer Cancer Foundation of the American Society of Clinical Oncology, a founding director of the All-Ireland Cancer Foundation, and a director of the American Cancer Society Foundation (2000-2009). He is the convener of ACT-China (Advanced Clinical Trials, China; Shukui QIN & Yi-Long WU, co-chairs), and member of the National Cancer Policy Forum (Dr. John Mendelsohn, chair) of The Institute of Medicine (IOM) of the United States National Academy of Sciences. He is a director of the Foundation for the National Institutes of Health (Dr. Charles Sanders, chairman), a member of the Board of Visitors of the UNC Lineberger Comprehensive Cancer Center, member of the Board of Advisors of the H. Lee Moffitt Cancer Center & Research Institute, and a charter member and director of C-Change, co-chaired by former President George H. W. Bush and former First Lady Barbara Bush; U.S. Senator Dianne Feinstein serves as vice chair. Queen’s University School of Medicine (Belfast)conferred upon him the Doctor of Medical Science degree.
Dr. Murphy is founding chief executive officer of the CEO Roundtable on Cancer, established in 2001 at the request of former President George H.W. Bush. He and Ann (nee Flesher) Murphy, PhD, were married in 1965; they have five children and ten grandchildren.